Letter to the Editor for “Metronomic Chemotherapy in Pediatric Neuroblastoma”

Ana Ivanovski; Dimitrije Nikolic; Ana Cirovic; Aleksandar Cirovic

doi:10.1002/pdi3.70003

Pediatric Discovery ›› 2025, Vol. 3 ›› Issue (2) : e70003 DOI: 10.1002/pdi3.70003

LETTER TO THE EDITOR

Letter to the Editor for “Metronomic Chemotherapy in Pediatric Neuroblastoma”

Author information +

History +

PDF

Cite this article

Download citation ▾

Ana Ivanovski, Dimitrije Nikolic, Ana Cirovic, Aleksandar Cirovic. Letter to the Editor for “Metronomic Chemotherapy in Pediatric Neuroblastoma”. Pediatric Discovery, 2025, 3(2): e70003 DOI:10.1002/pdi3.70003

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Y. Jiang, C. Xi, and C. Yang, “Metronomic Chemotherapy in Pediatric Neuroblastoma,” Pediatric Discovery 2, no. 4 (2024): e2512.

[2]	R. S. Kerbel and B. A. Kamen, “The Anti-angiogenic Basis of Metronomic Chemotherapy,” Nature Reviews Cancer 4, no. 6 (June 2004): 423–436, https://doi.org/10.1038/nrc1369.

[3]	D. Hanahan, G. Bergers, and E. Bergsland, “Less Is More, Regularly: Metronomic Dosing of Cytotoxic Drugs Can Target Tumor Angiogenesis in Mice,” Journal of Clinical Investigation 105, no. 8 (2000): 1045–1047.

[4]	P. Ivanovski, D. Milovanović, and Đ. Kokai, “Fibrolamellar Hepatocarcinoma: Case Report,” Medical and Pediatric Oncology 19, no. 5 (1991): 375–376.

RIGHTS & PERMISSIONS

2025 The Author(s). Pediatric Discovery published by John Wiley & Sons Australia, Ltd on behalf of Children's Hospital of Chongqing Medical University.